$28.34
-1.14-3.87%
In chiusura: Nov 20, 4:00 PM EST
$28.05
-0.29-1.02%
Post-mercato: 6:47 PM EST
The average analyst price target for Definium Therapeutics is $65.13, 132.2% above the current price. Of 16 analysts, 16 rate it Buy. Targets range from $25 to $90. The latest change came on Nov 17, 2026, when JP Morgan raised its price target on Definium Therapeutics from $84 to $85 and kept an Overweight rating.
Price Target Range — 4 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
